Hepatic complications of obesity

被引:23
作者
Diehl, AM [1 ]
机构
[1] Duke Univ, Ctr Med, Div Gastroenterol, Durham, NC 27710 USA
关键词
D O I
10.1016/j.gtc.2004.12.012
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This article details data pertinent to the diagnosis, prognosis, and treatment of people with obesity-related liver disease. It summarizes new information about the mechanisms that drive liver disease progression in obese individuals.
引用
收藏
页码:45 / +
页数:18
相关论文
共 65 条
[1]  
Abdelmalek MF, 2001, AM J GASTROENTEROL, V96, P2711
[2]   Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity [J].
Adinolfi, LE ;
Gambardella, M ;
Andreana, A ;
Tripodi, MF ;
Utili, R ;
Ruggiero, G .
HEPATOLOGY, 2001, 33 (06) :1358-1364
[3]   Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].
Angulo, P ;
Keach, JC ;
Batts, KP ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (06) :1356-1362
[4]   NONALCOHOLIC STEATOHEPATITIS - AN EXPANDED CLINICAL ENTITY [J].
BACON, BR ;
FARAHVASH, MJ ;
JANNEY, CG ;
NEUSCHWANDERTETRI, BA .
GASTROENTEROLOGY, 1994, 107 (04) :1103-1109
[5]   High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C [J].
Bressler, BL ;
Guindi, M ;
Tomlinson, G ;
Heathcote, J .
HEPATOLOGY, 2003, 38 (03) :639-644
[6]   Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions [J].
Brunt, EM ;
Janney, CG ;
Di Bisceglie, AM ;
Neuschwander-Tetri, BA ;
Bacon, BR .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (09) :2467-2474
[7]   Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease [J].
Caldwell, SH ;
Oelsner, DH ;
Iezzoni, JC ;
Hespenheide, EE ;
Battle, EH ;
Driscoll, CJ .
HEPATOLOGY, 1999, 29 (03) :664-669
[8]  
Caldwell SH, 2001, AM J GASTROENTEROL, V96, P519
[9]   Adipobiology of disease: Adipokines and adipokine-targeted pharmacology [J].
Chaldakov, GN ;
Stankulov, IS ;
Hristova, M ;
Ghenev, PI .
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (12) :1023-1031
[10]  
CLAIN DJ, 1987, GASTROENTEROL CLIN N, V16, P239